Annual Revenue
$40.11 B
-$3.54 B-8.12%
31 December 2023
Summary
Abbott Laboratories annual revenue is currently $40.11 billion, with the most recent change of -$3.54 billion (-8.12%) on 31 December 2023. During the last 3 years, it has risen by +$5.50 billion (+15.90%). ABT annual revenue is now -8.12% below its all-time high of $43.65 billion, reached on 31 December 2022.ABT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$10.63 B
+$258.00 M+2.49%
30 September 2024
Summary
Abbott Laboratories quarterly revenue is currently $10.63 billion, with the most recent change of +$258.00 million (+2.49%) on 30 September 2024. Over the past year, it has increased by +$492.00 million (+4.85%). ABT quarterly revenue is now -10.59% below its all-time high of $11.89 billion, reached on 31 March 2022.ABT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$41.22 B
+$492.00 M+1.21%
30 September 2024
Summary
Abbott Laboratories TTM revenue is currently $41.22 billion, with the most recent change of +$492.00 million (+1.21%) on 30 September 2024. Over the past year, it has increased by +$1.26 billion (+3.15%). ABT TTM revenue is now -9.51% below its all-time high of $45.55 billion, reached on 30 June 2022.ABT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | +4.8% | +3.1% |
| 3 y3 years | +15.9% | -2.7% | -2.6% |
| 5 y5 years | +31.2% | +31.7% | +31.4% |
ABT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.1% | +15.9% | -10.6% | +9.1% | -9.5% | +3.1% |
| 5 y | 5 years | -8.1% | +31.2% | -10.6% | +45.1% | -9.5% | +31.4% |
| alltime | all time | -8.1% | +1192.2% | -10.6% | +250.5% | -9.5% | +5615.9% |
Abbott Laboratories Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.63 B(+2.5%) | $41.22 B(+1.2%) |
| June 2024 | - | $10.38 B(+4.1%) | $40.73 B(+1.0%) |
| Mar 2024 | - | $9.96 B(-2.7%) | $40.33 B(+0.5%) |
| Dec 2023 | $40.11 B(-8.1%) | $10.24 B(+1.0%) | $40.11 B(+0.4%) |
| Sept 2023 | - | $10.14 B(+1.7%) | $39.96 B(-0.7%) |
| June 2023 | - | $9.98 B(+2.4%) | $40.23 B(-3.1%) |
| Mar 2023 | - | $9.75 B(-3.4%) | $41.51 B(-4.9%) |
| Dec 2022 | $43.65 B(+1.3%) | $10.09 B(-3.1%) | $43.65 B(-3.1%) |
| Sept 2022 | - | $10.41 B(-7.5%) | $45.03 B(-1.1%) |
| June 2022 | - | $11.26 B(-5.4%) | $45.55 B(+2.3%) |
| Mar 2022 | - | $11.89 B(+3.7%) | $44.51 B(+3.3%) |
| Dec 2021 | $43.08 B(+24.5%) | $11.47 B(+4.9%) | $43.08 B(+1.8%) |
| Sept 2021 | - | $10.93 B(+6.9%) | $42.31 B(+5.2%) |
| June 2021 | - | $10.22 B(-2.2%) | $40.23 B(+7.8%) |
| Mar 2021 | - | $10.46 B(-2.3%) | $37.34 B(+7.9%) |
| Dec 2020 | $34.61 B(+8.5%) | $10.70 B(+20.9%) | $34.61 B(+7.4%) |
| Sept 2020 | - | $8.85 B(+20.8%) | $32.22 B(+2.5%) |
| June 2020 | - | $7.33 B(-5.2%) | $31.44 B(-2.0%) |
| Mar 2020 | - | $7.73 B(-7.1%) | $32.09 B(+0.6%) |
| Dec 2019 | $31.90 B(+4.3%) | $8.31 B(+2.9%) | $31.90 B(+1.8%) |
| Sept 2019 | - | $8.08 B(+1.2%) | $31.36 B(+1.4%) |
| June 2019 | - | $7.98 B(+5.9%) | $30.93 B(+0.7%) |
| Mar 2019 | - | $7.54 B(-3.0%) | $30.72 B(+0.5%) |
| Dec 2018 | $30.58 B(+11.6%) | $7.76 B(+1.4%) | $30.58 B(+0.6%) |
| Sept 2018 | - | $7.66 B(-1.4%) | $30.40 B(+2.8%) |
| June 2018 | - | $7.77 B(+5.1%) | $29.57 B(+4.0%) |
| Mar 2018 | - | $7.39 B(-2.6%) | $28.45 B(+3.9%) |
| Dec 2017 | $27.39 B(+31.3%) | $7.59 B(+11.1%) | $27.39 B(+9.0%) |
| Sept 2017 | - | $6.83 B(+2.9%) | $25.13 B(+6.5%) |
| June 2017 | - | $6.64 B(+4.8%) | $23.61 B(+5.8%) |
| Mar 2017 | - | $6.33 B(+18.8%) | $22.30 B(+7.0%) |
| Dec 2016 | $20.85 B(+2.2%) | $5.33 B(+0.6%) | $20.85 B(+0.7%) |
| Sept 2016 | - | $5.30 B(-0.6%) | $20.71 B(+0.7%) |
| June 2016 | - | $5.33 B(+9.2%) | $20.56 B(+0.8%) |
| Mar 2016 | - | $4.88 B(-5.8%) | $20.39 B(-0.1%) |
| Dec 2015 | $20.41 B(+0.8%) | $5.19 B(+0.7%) | $20.41 B(-0.8%) |
| Sept 2015 | - | $5.15 B(-0.4%) | $20.57 B(+0.3%) |
| June 2015 | - | $5.17 B(+5.6%) | $20.50 B(+0.6%) |
| Mar 2015 | - | $4.90 B(-8.6%) | $20.39 B(+0.7%) |
| Dec 2014 | $20.25 B(+3.0%) | $5.36 B(+5.5%) | $20.25 B(+1.7%) |
| Sept 2014 | - | $5.08 B(+0.4%) | $19.91 B(+1.3%) |
| June 2014 | - | $5.06 B(+6.4%) | $19.65 B(-1.9%) |
| Mar 2014 | - | $4.75 B(-5.2%) | $20.04 B(-3.0%) |
| Dec 2013 | $19.66 B(+3.2%) | $5.01 B(+3.9%) | $20.66 B(+9.7%) |
| Sept 2013 | - | $4.83 B(-11.4%) | $18.84 B(-2.3%) |
| June 2013 | - | $5.45 B(+1.3%) | $19.28 B(+0.7%) |
| Mar 2013 | - | $5.38 B(+68.7%) | $19.14 B(+0.5%) |
| Dec 2012 | $19.05 B(-11.0%) | $3.19 B(-39.4%) | $19.05 B(+116.6%) |
| Sept 2012 | - | $5.26 B(-0.9%) | $8.79 B(-34.1%) |
| June 2012 | - | $5.31 B(+0.6%) | $13.35 B(-24.4%) |
| Mar 2012 | - | $5.28 B(-174.8%) | $17.65 B(-17.6%) |
| Dec 2011 | $21.41 B(-39.1%) | -$7.07 B(-172.0%) | $21.41 B(-44.3%) |
| Sept 2011 | - | $9.82 B(+2.1%) | $38.44 B(+3.1%) |
| June 2011 | - | $9.62 B(+6.4%) | $37.30 B(+2.2%) |
| Mar 2011 | - | $9.04 B(-9.3%) | $36.51 B(+3.8%) |
| Dec 2010 | $35.17 B(+14.3%) | $9.97 B(+14.9%) | $35.17 B(+3.5%) |
| Sept 2010 | - | $8.67 B(-1.7%) | $33.99 B(+2.8%) |
| June 2010 | - | $8.83 B(+14.6%) | $33.08 B(+4.2%) |
| Mar 2010 | - | $7.70 B(-12.4%) | $31.74 B(+3.2%) |
| Dec 2009 | $30.76 B(+4.2%) | $8.79 B(+13.3%) | $30.76 B(+2.8%) |
| Sept 2009 | - | $7.76 B(+3.6%) | $29.92 B(+0.9%) |
| June 2009 | - | $7.49 B(+11.6%) | $29.66 B(+0.6%) |
| Mar 2009 | - | $6.72 B(-15.5%) | $29.48 B(-0.2%) |
| Dec 2008 | $29.53 B(+13.9%) | $7.95 B(+6.0%) | $29.53 B(+2.5%) |
| Sept 2008 | - | $7.50 B(+2.5%) | $28.80 B(+4.1%) |
| June 2008 | - | $7.31 B(+8.1%) | $27.68 B(+3.5%) |
| Mar 2008 | - | $6.77 B(-6.3%) | $26.73 B(+3.2%) |
| Dec 2007 | $25.91 B(+15.3%) | $7.22 B(+13.2%) | $25.91 B(+4.0%) |
| Sept 2007 | - | $6.38 B(+0.1%) | $24.91 B(+3.3%) |
| June 2007 | - | $6.37 B(+7.1%) | $24.11 B(+3.7%) |
| Mar 2007 | - | $5.95 B(-4.4%) | $23.24 B(+6.2%) |
| Dec 2006 | $22.48 B(+0.6%) | $6.22 B(+11.6%) | $21.87 B(+0.8%) |
| Sept 2006 | - | $5.57 B(+1.3%) | $21.70 B(+0.9%) |
| June 2006 | - | $5.50 B(+20.1%) | $21.51 B(-0.1%) |
| Mar 2006 | - | $4.58 B(-24.3%) | $21.54 B(-3.6%) |
| Dec 2005 | $22.34 B(+13.5%) | $6.05 B(+12.3%) | $22.34 B(+1.8%) |
| Sept 2005 | - | $5.38 B(-2.5%) | $21.94 B(+3.3%) |
| June 2005 | - | $5.52 B(+2.6%) | $21.24 B(+4.0%) |
| Mar 2005 | - | $5.38 B(-4.8%) | $20.42 B(+3.8%) |
| Dec 2004 | $19.68 B | $5.65 B(+20.8%) | $19.68 B(+4.0%) |
| Sept 2004 | - | $4.68 B(-0.5%) | $18.92 B(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $4.70 B(+1.3%) | $18.49 B(+3.2%) |
| Mar 2004 | - | $4.64 B(-5.2%) | $17.91 B(+0.3%) |
| Dec 2003 | $17.28 B(+13.1%) | $4.90 B(+15.3%) | $17.85 B(+16.0%) |
| Sept 2003 | - | $4.25 B(+2.9%) | $15.39 B(-0.6%) |
| June 2003 | - | $4.13 B(-9.9%) | $15.48 B(-1.2%) |
| Mar 2003 | - | $4.58 B(+88.2%) | $15.67 B(+2.6%) |
| Dec 2002 | $15.28 B(-6.2%) | $2.43 B(-43.9%) | $15.28 B(-11.6%) |
| Sept 2002 | - | $4.34 B(+0.6%) | $17.29 B(+0.9%) |
| June 2002 | - | $4.31 B(+3.0%) | $17.13 B(+1.3%) |
| Mar 2002 | - | $4.19 B(-5.8%) | $16.91 B(+3.9%) |
| Dec 2001 | $16.29 B(+18.5%) | $4.45 B(+6.3%) | $16.29 B(+4.8%) |
| Sept 2001 | - | $4.18 B(+2.0%) | $15.54 B(+5.9%) |
| June 2001 | - | $4.10 B(+15.1%) | $14.68 B(+5.2%) |
| Mar 2001 | - | $3.56 B(-3.9%) | $13.95 B(+1.5%) |
| Dec 2000 | $13.75 B(+4.3%) | $3.70 B(+11.7%) | $13.75 B(+1.8%) |
| Sept 2000 | - | $3.32 B(-1.6%) | $13.51 B(+1.4%) |
| June 2000 | - | $3.37 B(+0.5%) | $13.33 B(+0.8%) |
| Mar 2000 | - | $3.35 B(-3.3%) | $13.22 B(+0.3%) |
| Dec 1999 | $13.18 B(+5.3%) | $3.47 B(+10.5%) | $13.18 B(+0.8%) |
| Sept 1999 | - | $3.14 B(-3.7%) | $13.07 B(+0.8%) |
| June 1999 | - | $3.26 B(-1.6%) | $12.97 B(+1.5%) |
| Mar 1999 | - | $3.31 B(-1.5%) | $12.78 B(+2.1%) |
| Dec 1998 | $12.51 B(+5.2%) | $3.37 B(+10.9%) | $12.51 B(+2.0%) |
| Sept 1998 | - | $3.04 B(-1.0%) | $12.27 B(+1.4%) |
| June 1998 | - | $3.07 B(+0.7%) | $12.10 B(+1.4%) |
| Mar 1998 | - | $3.04 B(-2.5%) | $11.93 B(+0.4%) |
| Dec 1997 | $11.89 B(+8.0%) | $3.12 B(+9.0%) | $11.89 B(+1.1%) |
| Sept 1997 | - | $2.87 B(-1.2%) | $11.76 B(+1.9%) |
| June 1997 | - | $2.90 B(-3.3%) | $11.54 B(+1.8%) |
| Mar 1997 | - | $3.00 B(+0.1%) | $11.34 B(+3.0%) |
| Dec 1996 | $11.01 B(+10.0%) | $3.00 B(+13.2%) | $11.01 B(+3.8%) |
| Sept 1996 | - | $2.65 B(-2.0%) | $10.61 B(+2.5%) |
| June 1996 | - | $2.70 B(+1.0%) | $10.36 B(+2.0%) |
| Mar 1996 | - | $2.67 B(+2.9%) | $10.16 B(+1.5%) |
| Dec 1995 | $10.01 B(+9.4%) | $2.60 B(+8.6%) | $10.01 B(+1.2%) |
| Sept 1995 | - | $2.39 B(-4.4%) | $9.90 B(+1.4%) |
| June 1995 | - | $2.50 B(-1.0%) | $9.76 B(+3.1%) |
| Mar 1995 | - | $2.52 B(+1.7%) | $9.47 B(+3.4%) |
| Dec 1994 | $9.16 B(+8.9%) | $2.48 B(+10.1%) | $9.16 B(+2.9%) |
| Sept 1994 | - | $2.25 B(+2.3%) | $8.90 B(+2.2%) |
| June 1994 | - | $2.20 B(-0.5%) | $8.71 B(+1.5%) |
| Mar 1994 | - | $2.22 B(-0.6%) | $8.58 B(+2.0%) |
| Dec 1993 | $8.41 B(+7.1%) | $2.23 B(+8.1%) | $8.41 B(+1.6%) |
| Sept 1993 | - | $2.06 B(-0.6%) | $8.28 B(+1.1%) |
| June 1993 | - | $2.07 B(+1.4%) | $8.18 B(+2.1%) |
| Mar 1993 | - | $2.05 B(-2.4%) | $8.02 B(+2.1%) |
| Dec 1992 | $7.85 B(+14.2%) | $2.10 B(+6.5%) | $7.85 B(+2.8%) |
| Sept 1992 | - | $1.97 B(+3.1%) | $7.64 B(+4.3%) |
| June 1992 | - | $1.91 B(+1.6%) | $7.33 B(+3.2%) |
| Mar 1992 | - | $1.88 B(-0.4%) | $7.10 B(+3.3%) |
| Dec 1991 | $6.88 B(+11.7%) | $1.89 B(+14.1%) | $6.88 B(+2.6%) |
| Sept 1991 | - | $1.65 B(-1.7%) | $6.70 B(+2.2%) |
| June 1991 | - | $1.68 B(+1.8%) | $6.55 B(+2.8%) |
| Mar 1991 | - | $1.65 B(-3.3%) | $6.37 B(+3.5%) |
| Dec 1990 | $6.16 B(+14.5%) | $1.71 B(+13.5%) | $6.16 B(+4.3%) |
| Sept 1990 | - | $1.51 B(+0.2%) | $5.90 B(+3.4%) |
| June 1990 | - | $1.50 B(+4.5%) | $5.71 B(+3.3%) |
| Mar 1990 | - | $1.44 B(-1.2%) | $5.52 B(+2.7%) |
| Dec 1989 | $5.38 B(+9.0%) | $1.46 B(+11.1%) | $5.38 B(+2.9%) |
| Sept 1989 | - | $1.31 B(-0.6%) | $5.23 B(+1.9%) |
| June 1989 | - | $1.32 B(+1.8%) | $5.13 B(+1.8%) |
| Mar 1989 | - | $1.30 B(-0.8%) | $5.04 B(+2.2%) |
| Dec 1988 | $4.94 B(+12.5%) | $1.31 B(+7.7%) | $4.94 B(+1.5%) |
| Sept 1988 | - | $1.21 B(-1.4%) | $4.86 B(+2.6%) |
| June 1988 | - | $1.23 B(+3.5%) | $4.74 B(+3.7%) |
| Mar 1988 | - | $1.19 B(-3.7%) | $4.57 B(+4.2%) |
| Dec 1987 | $4.39 B(+15.2%) | $1.23 B(+13.1%) | $4.39 B(+4.0%) |
| Sept 1987 | - | $1.09 B(+2.9%) | $4.22 B(+3.7%) |
| June 1987 | - | $1.06 B(+5.5%) | $4.07 B(+3.1%) |
| Mar 1987 | - | $1.00 B(-5.6%) | $3.95 B(+3.6%) |
| Dec 1986 | $3.81 B(+13.3%) | $1.06 B(+13.0%) | $3.81 B(+2.9%) |
| Sept 1986 | - | $940.90 M(+0.3%) | $3.70 B(+3.3%) |
| June 1986 | - | $938.00 M(+8.4%) | $3.58 B(+3.2%) |
| Mar 1986 | - | $865.50 M(-9.3%) | $3.47 B(+3.3%) |
| Dec 1985 | $3.36 B(+8.3%) | $954.40 M(+16.0%) | $3.36 B(+3.2%) |
| Sept 1985 | - | $822.70 M(-0.5%) | $3.26 B(+2.9%) |
| June 1985 | - | $827.00 M(+9.4%) | $3.16 B(+0.8%) |
| Mar 1985 | - | $756.20 M(-11.1%) | $3.14 B(+1.1%) |
| Dec 1984 | $3.10 B | $850.40 M(+16.3%) | $3.10 B(+37.7%) |
| Sept 1984 | - | $731.20 M(-8.8%) | $2.25 B(+48.0%) |
| June 1984 | - | $801.40 M(+11.1%) | $1.52 B(+111.1%) |
| Mar 1984 | - | $721.10 M | $721.10 M |
FAQ
- What is Abbott Laboratories annual revenue?
- What is the all time high annual revenue for Abbott Laboratories?
- What is Abbott Laboratories annual revenue year-on-year change?
- What is Abbott Laboratories quarterly revenue?
- What is the all time high quarterly revenue for Abbott Laboratories?
- What is Abbott Laboratories quarterly revenue year-on-year change?
- What is Abbott Laboratories TTM revenue?
- What is the all time high TTM revenue for Abbott Laboratories?
- What is Abbott Laboratories TTM revenue year-on-year change?
What is Abbott Laboratories annual revenue?
The current annual revenue of ABT is $40.11 B
What is the all time high annual revenue for Abbott Laboratories?
Abbott Laboratories all-time high annual revenue is $43.65 B
What is Abbott Laboratories annual revenue year-on-year change?
Over the past year, ABT annual revenue has changed by -$3.54 B (-8.12%)
What is Abbott Laboratories quarterly revenue?
The current quarterly revenue of ABT is $10.63 B
What is the all time high quarterly revenue for Abbott Laboratories?
Abbott Laboratories all-time high quarterly revenue is $11.89 B
What is Abbott Laboratories quarterly revenue year-on-year change?
Over the past year, ABT quarterly revenue has changed by +$492.00 M (+4.85%)
What is Abbott Laboratories TTM revenue?
The current TTM revenue of ABT is $41.22 B
What is the all time high TTM revenue for Abbott Laboratories?
Abbott Laboratories all-time high TTM revenue is $45.55 B
What is Abbott Laboratories TTM revenue year-on-year change?
Over the past year, ABT TTM revenue has changed by +$1.26 B (+3.15%)